YU47559B - Postupak za dobijanje derivata 2-piperidino-1-alkanola - Google Patents

Postupak za dobijanje derivata 2-piperidino-1-alkanola

Info

Publication number
YU47559B
YU47559B YU95890A YU95890A YU47559B YU 47559 B YU47559 B YU 47559B YU 95890 A YU95890 A YU 95890A YU 95890 A YU95890 A YU 95890A YU 47559 B YU47559 B YU 47559B
Authority
YU
Yugoslavia
Prior art keywords
hydrogen
alkyl
previously defined
nhr1
independently
Prior art date
Application number
YU95890A
Other languages
English (en)
Other versions
YU95890A (en
Inventor
B.L. Chenard
Original Assignee
Prizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1989/002176 external-priority patent/WO1990014087A1/en
Application filed by Prizer Inc. filed Critical Prizer Inc.
Publication of YU95890A publication Critical patent/YU95890A/xx
Publication of YU47559B publication Critical patent/YU47559B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Abstract

POSTUPAK ZA DOBIJANJE DERIVATA 2-PIPERIDINO-1-ALKANOLA, formule: u kojoj je R, H, (C1-C6)alkilm (C2-C6)alkenil ili (C2-C6)alkinil; Q je S ili CH=CH; X je vodonik, (C1-C3)alkil, halogen, OR1, OCOR1, CO2R1, SR1, NHR1, NHCOR1, CONH2 ili CN; R1 je vodonik, ili (C1-C3) alkil; Y i Y1 su uzeti zajedno i predstavljau: ili su Y i Y1 uzeti zajedno i Y je vodonik ili OH a Y1 je ili je Y vodonik a Y1 je n je 0, 1, 2 ili 3; m je 0, 1, 2, 3 ili 4; Q je nezavisno vrednost Q kako je prethodno definisano; X1 je nezavisno vrednost X kako je prethodno definisano; Z je O, S, SO, ili SO2; ili njihovih farmaceutski prih-vatljivih kiselinskih adicionih soli; naznačen time, što obuhvata hidridnu redukciju jedinjenja formule: u kojoj je X2 vodonik, (C1-C3)alkil, halogen, OR1, OR2, OCOR1, COOR1, SR1, SR2, NHR1, NR1R3, NHCOR1, CONH2 ili CN; Q, R i R1 su kako je prethodno definisano; R2 je oubičajena hidroksi ili merkaptanska zaštitna grupa; R3 je uobiča jena amino zaštitna grupa; Y5 i Y6 su uzeti zajendo i predstavljaju: ili su Y5 i Y6 uzeti odvojeno i Y5 je vodonik ili OH, a Y6 je ili je Y5 vodonik a Y6 je n, m, Q1 i Z su prethodno definisani; X3 je nezavisno vrednost X2 kao što je prethodno definisano; Z je O, S, SO ili SO2; i što se uobičajeno otklanjaju navedene zaštitne grupe RR2 i R3 kada je X ili X1 OH, SH ili NHR1 a X2 ili X3 su OR2, SR2, ili NR1R3. Prijava sadrži još 22 zavisna zahteva.
YU95890A 1989-05-17 1990-05-16 Postupak za dobijanje derivata 2-piperidino-1-alkanola YU47559B (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1989/002176 WO1990014087A1 (en) 1989-05-17 1989-05-17 2-piperidino-1-alkanol derivatives as antiischemic agents
PCT/US1990/000292 WO1990014088A1 (en) 1989-05-17 1990-01-16 2-piperidino-1-alkanol derivatives as antiischemic agents

Publications (2)

Publication Number Publication Date
YU95890A YU95890A (en) 1992-05-28
YU47559B true YU47559B (sh) 1995-10-03

Family

ID=26779691

Family Applications (1)

Application Number Title Priority Date Filing Date
YU95890A YU47559B (sh) 1989-05-17 1990-05-16 Postupak za dobijanje derivata 2-piperidino-1-alkanola

Country Status (9)

Country Link
EP (1) EP0398578B1 (sh)
AU (1) AU618191B2 (sh)
CA (1) CA2016860C (sh)
DD (1) DD294484A5 (sh)
ES (1) ES2098248T3 (sh)
GR (1) GR3023314T3 (sh)
NZ (1) NZ233685A (sh)
PT (1) PT94045B (sh)
YU (1) YU47559B (sh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642994B2 (en) * 1990-05-10 1993-11-04 Pfizer Inc. Neuroprotective indolone and related derivatives
CZ284133B6 (cs) * 1991-07-17 1998-08-12 Pfizer Inc. 2-/4-Hydroxypiperidino/-1-alkanolové deriváty jako antiischemická činidla. způsob jejich přípravy a použití.
US6255322B1 (en) 1992-06-19 2001-07-03 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
PL173618B1 (pl) * 1992-10-30 1998-04-30 Pfizer Związki 6-[2-(4-hydroksy-4-fenylopiperydyno)-1-hydroksypropylo]-3,4-dihydro-2(1H)-chinolonowe
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672644B2 (en) * 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
TW281670B (sh) * 1993-09-02 1996-07-21 Hoffmann La Roche
HUT77520A (hu) * 1994-08-18 1998-05-28 Pfizer Inc. Neuroprotektív hatású kromán-4,7-diol- és 1-(4-hidroxifenil)-alkanol-származékok és azokat hatóanyagként tartalmazó gyógyszerkészítmények
GB9510459D0 (en) 1995-05-24 1995-07-19 Zeneca Ltd Bicyclic amines
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
CZ287821B6 (en) * 1996-05-13 2001-02-14 Zeneca Ltd Bicyclic amines, process of their preparation and insecticidal, acaricidal and nematocidal agent containing thereof
GB9623944D0 (en) * 1996-11-15 1997-01-08 Zeneca Ltd Bicyclic amine derivatives
GB9624114D0 (en) * 1996-11-20 1997-01-08 Zeneca Ltd Pesticidal bicyclic amine derivatives
GB9624611D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Bicyclic amine compounds
CA2271749A1 (en) 1996-11-26 1998-06-18 Christopher Richard Ayles Godfrey 8-azabicyclo¬3.2.1|octane-, 8-azabicyclo¬3.2.1|oct-6-ene-, 9-azabicyclo¬3.3.1|nonane-, 9-aza-3-oxabicyclo¬3.3.1|nonane- and 9-aza-3-thiabicyclo¬3.3.1|nonane derivatives, their preparation and their use as insecticides
WO2003062235A1 (en) 2002-01-17 2003-07-31 Eli Lilly And Company Modulators of acetylcholine receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045688A1 (de) * 1980-12-04 1982-07-08 C.H. Boehringer Sohn, 6507 Ingelheim Neue 8-arylalkyl-3-phenyl-3-nortropanole, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0076089A3 (en) * 1981-09-28 1983-05-25 Beecham Group Plc Azabicycloalkane derivatives, process for their preparation, and a pharmaceutical composition containing them
US4366154A (en) * 1981-11-09 1982-12-28 Sandoz, Inc. Tropyl derivatives
JPS6136262A (ja) * 1984-07-26 1986-02-20 Nippon Iyakuhin Kogyo Kk ピペリジノ−プロパノンもしくは−プロパノール誘導体及びその製法

Also Published As

Publication number Publication date
PT94045B (pt) 1996-12-31
CA2016860C (en) 1998-07-28
DD294484A5 (de) 1991-10-02
EP0398578A2 (en) 1990-11-22
ES2098248T3 (es) 1997-05-01
EP0398578B1 (en) 1997-03-12
AU5512590A (en) 1990-11-22
NZ233685A (en) 1992-10-28
GR3023314T3 (en) 1997-08-29
PT94045A (pt) 1991-01-08
EP0398578A3 (en) 1991-12-11
CA2016860A1 (en) 1990-11-17
AU618191B2 (en) 1991-12-12
YU95890A (en) 1992-05-28

Similar Documents

Publication Publication Date Title
YU47559B (sh) Postupak za dobijanje derivata 2-piperidino-1-alkanola
RS49531B (sr) Estrogen agonisti/antagonisti
KR950700894A (ko) 탁솔 유도체(Taxol derivatives)
NO2006002I1 (no) Posakonzol eventuelt i form av en ester og/eller et farmasoytisk akseptabelt salt derav (se kopi frausp dictionary med strukturformel)
HUP0203514A2 (hu) Kinuklidin vegyületek és ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
ATE22889T1 (de) 8-chlor-1,5-benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ATE202337T1 (de) Cyclopropylalkansäurederivate
MY130125A (en) Ureido derivatives of naphthalenephosphonic acids and process for their preparation
EP1175208A4 (en) COMPOSITION FOR PREVENTION OR TREATMENT OF DEMENTIA CONTAINING A HYDROXYCINNAMIC ACID DERIVATIVE OR AN EXTRACT OF AN ANGELICAE SPECIES CONTAINING SAID ACID
BE2014C034I2 (en) Derivatives of 3-(2-oxo- 1,3&#39;]bipyrrolidinyl-3-ylidenemethyl)-cephems
ES557417A0 (es) Un procedimiento para la preparacion de un polimero de elevada elasticidad y dureza
AU541413B2 (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
ES8800122A1 (es) Un procedimiento para la preparacion de derivados de indeno y naftaleno.
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
AU1842897A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
KR890001965A (ko) 스퍼구알린 관련 유도체
DE69629474D1 (de) Antifungale tetrahydrofurane
IE810232L (en) Phenyl hydroxyalkyl ethers and thioethers
DK0904270T3 (da) Dihydrobenzofuran og beslægtede forbindelser anvendelige som antiinflammatoriske midler
JPS53111096A (en) 1-azaxanthone-3-carboxylic acid derivative and its preparation
TW334337B (en) Preparation and composition for a compound of controlling and preventing phytopathogenic fungi
PL313708A1 (en) Novel anthracyclin disaccharides, method of obtaining and preparation containing them
IE881752L (en) New aminoacylates of glycerol acetal
YU48204B (sh) Neuro-zaštitni derivati 3-piperidino-4-hidroksihromana i postupak za njihovo dobijanje